Galexia assisted Diabetes Australia with a high level privacy review of the National Diabetes Services Scheme (NDSS) - considering the operation of the Australian Privacy Principles (APPs) and new guidance from the Office of the Australian Information Commission (OAIC). The NDSS is one of the largest active health based consent databases in Australia and privacy governance is critical. The data includes specific interactions with pharmacies and the provision of pharmaceutical services in Australia.
- Identification and prioritisation privacy issues
- Gaps in policies and procedures
- Any potential future issues, and
- Assist Diabetes Australia develop a work plan and priorities for the ongoing governance of privacy issues in the NDSS.